Evoke Pharma, Inc. Profile Avatar - Palmy Investing

Evoke Pharma, Inc.

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has co…

Drug Manufacturers - Specialty & Generic
US, Solana Beach [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Evoke Pharma, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of EVOK's Analysis
CIK: 1403708 CUSIP: 30049G104 ISIN: US30049G2030 LEI: - UEI: -
Secondary Listings
EVOK has no secondary listings inside our databases.